{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:28:02Z","timestamp":1761182882948,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Meiji Seika Pharma Co., Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jiac.2014.05.007","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T09:01:16Z","timestamp":1403686876000},"page":"607-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics of arbekacin in bronchial epithelial lining fluid of healthy volunteers"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0474-2672","authenticated-orcid":false,"given":"Yohei","family":"Funatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho","family":"Namkoong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Asami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadatomo","family":"Tasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Kimizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Iketani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Betsuyaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2014.05.007_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1378\/chest.08-1357","article-title":"Health-care-associated pneumonia among hospitalized patients in a japanese community hospital","volume":"135","author":"Shindo","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2014.05.007_bib2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"Nhsn annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006\u20132007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol Off J Soc Hosp Epidemiol Am"},{"key":"10.1016\/j.jiac.2014.05.007_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10156-012-0454-z","article-title":"The definition of healthcare-associated pneumonia (hcap) is insufficient for the medical environment in japan: a comparison of hcap and nursing and healthcare-associated pneumonia (nhcap)","volume":"19","author":"Kaku","year":"2013","journal-title":"J\u00a0Infect Chemother Off J Jpn Soc Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the clinical and laboratory standards institute vancomycin minimal inhibitory concentration interpretive criteria for staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2014.05.007_bib5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin mic creep in non-vancomycin-intermediate staphylococcus aureus (visa), vancomycin-susceptible clinical methicillin-resistant S.\u00a0Aureus (mrsa) blood isolates from 2001\u201305","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib6","first-page":"412","article-title":"Letter: syntheses of 1-n-(s)-4-amino-2-hydroxybutyryl)-kanamycin b and -3', 4'-dideoxykanamycin b active against kanamycin-resistant bacteria","volume":"26","author":"Kondo","year":"1973","journal-title":"J\u00a0Antibiotics"},{"key":"10.1016\/j.jiac.2014.05.007_bib7","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1128\/AAC.00480-05","article-title":"Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant staphylococcus aureus","volume":"50","author":"Sato","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib8","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1128\/AAC.00420-05","article-title":"Population pharmacokinetics of arbekacin in patients infected with methicillin-resistant staphylococcus aureus","volume":"50","author":"Tanigawara","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/AAC.32.3.289","article-title":"Role of pharmacokinetics in the outcome of infections","volume":"32","author":"Drusano","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00133-06","article-title":"Interpretation of antibiotic concentration ratios measured in epithelial lining fluid","volume":"52","author":"Kiem","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00003246-200102000-00030","article-title":"Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock","volume":"29","author":"Joukhadar","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2014.05.007_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1378\/chest.128.2.545","article-title":"Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia","volume":"128","author":"Panidis","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2014.05.007_bib13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1179\/joc.1995.7.4.363","article-title":"Tissue penetration and pulmonary disposition of tobramycin","volume":"7","author":"Mazzei","year":"1995","journal-title":"J\u00a0Chemother (Florence, Italy)"},{"key":"10.1016\/j.jiac.2014.05.007_bib14","first-page":"338","article-title":"Bronchoscopic microsampling to analyze the epithelial lining fluid of patients with pulmonary mycobacterium avium complex disease","volume":"76","author":"Nishimura","year":"2008","journal-title":"Respir Int Rev Thorac Dis"},{"key":"10.1016\/j.jiac.2014.05.007_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pupt.2008.11.004","article-title":"Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with mycobacterium avium complex pulmonary disease","volume":"22","author":"Hasegawa","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jiac.2014.05.007_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1440-1843.2007.01208.x","article-title":"Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid","volume":"13","author":"Kikuchi","year":"2008","journal-title":"Respirol Carlt Vic"},{"key":"10.1016\/j.jiac.2014.05.007_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/00003246-200104000-00043","article-title":"New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome","volume":"29","author":"Ishizaka","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2014.05.007_bib18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1164\/rccm.200301-111OC","article-title":"Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid","volume":"168","author":"Yamazaki","year":"2003","journal-title":"Am J Respir Critical Care Med"},{"key":"10.1016\/j.jiac.2014.05.007_bib19","first-page":"200","article-title":"pharmacokinetics of arbekacin in healthy volunteers and patients with renal insufficiency","volume":"42","author":"Kumon","year":"1989","journal-title":"Jpn J Antibiotics"},{"key":"10.1016\/j.jiac.2014.05.007_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/phar.1323","article-title":"Clinical laboratory-based assay methodologies may underestimate and increase variability of vancomycin protein binding in hospitalized patients","volume":"34","author":"Crandon","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2014.05.007_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1365-2125.1976.tb00643.x","article-title":"Serum and lung tissue levels of cephradine in thoracic surgery","volume":"3","author":"Kiss","year":"1976","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2014.05.007_bib22","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/AAC.31.9.1312","article-title":"Pulmonary disposition of roxithromycin (ru 28965), a new macrolide antibiotic","volume":"31","author":"Chastre","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/j.1875-9114.1998.tb03824.x","article-title":"Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy","volume":"18","author":"Lee","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2014.05.007_bib24","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.01578-08","article-title":"Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusions","volume":"53","author":"Kikuchi","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10156-012-0434-3","volume":"18","author":"Watanabe","year":"2012","journal-title":"J\u00a0Infect Chemother Off J Jpn Soc Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib26","first-page":"126","article-title":"The role of pharmacodynamics in effective treatment of community-acquired pathogens","author":"WA","year":"2002","journal-title":"Adv Stud Med"},{"key":"10.1016\/j.jiac.2014.05.007_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jiac.2014.05.007_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/AAC.37.2.281","article-title":"Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients","volume":"37","author":"Lamer","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.05.007_bib29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.CCM.0000168206.59873.80","article-title":"Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia*","volume":"33","author":"Boselli","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2014.05.007_bib30","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1128\/AAC.44.7.1925-1929.2000","article-title":"In\u00a0vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and\/or in combination against glycopeptide intermediate-resistant staphylococcus aureus in an infection model","volume":"44","author":"Akins","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14002153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14002153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:52:13Z","timestamp":1761159133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X14002153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S1341321X14002153"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2014.05.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of arbekacin in bronchial epithelial lining fluid of healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2014.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}